Abstract 4631: Evaluation of the impact of homozygous MTAP truncations on the activity and selectivity of MTA-cooperative PRMT5 inhibitorsMatthew R. Tonini, Kimberly J. Briggs, Hannah Stowe et al.|Cancer Research|2024Cited by 1
Abstract 5584: Experimental ‘loss-of function’ annotation of STK11 mutations with prognostic and therapeutic implications (TNG260mutationfinder.com)Leanne G. Ahronian, Teng Teng, Preksha Shahagadkar et al.|Cancer Research|2024Cited by 0
Abstract 4608: Evaluation of the impact of homozygous MTAP truncations on the clinical activity of MTA-cooperative PRMT5 inhibitorsKimberly J. Briggs, Adam Crystal, Andre Mignault et al.|Cancer Research|2025Cited by 0
CHK1 Alleviates Doxorubicin-Induced Cardiotoxicity via Activating AKT/mTOR Pathway in MiceHaiyang Ni, See PDF, Yulan Ma et al.|SSRN Electronic Journal|2025Cited by 0